Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 107919
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107919
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107919
Figure 6 Imaging features and pathological manifestations of pancreatic cancer patients in the Ki-67 high-expression group.
A: Image in the arterial phase, with enhancement pattern type III. The arrow indicates the tumor lesion; B: Image in the venous phase, with enhancement pattern type III. The arrow indicates the tumor lesion; C: The time-intensity curve. The X-axis represents time (second), and the Y-axis represents signal intensity (%). The orange curve represents the surrounding normal pancreatic tissue, and the green curve represents pancreatic cancer; D: The pathological section stained with hematoxylin-eosin (HE) shows pancreatic ductal adenocarcinoma (HE, × 100). TIC: Time-intensity curve.
- Citation: Yang ZY, Wan WN, Zhao L, Li SN, Liu Z, Sang L. Noninvasive prediction of Ki-67 expression in pancreatic cancer via contrast-enhanced ultrasound quantitative parameters: A diagnostic model study. World J Gastrointest Oncol 2025; 17(6): 107919
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/107919.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.107919